NCT03739931 2025-08-15Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced MalignanciesModernaTX, Inc.Phase 1 Completed134 enrolled
NCT02643303 2022-12-02A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersLudwig Institute for Cancer ResearchPhase 1/2 Completed58 enrolled 24 charts